APRE · Aprea Therapeutics, Inc.
BUY 91%
28
Total trades
11
Insiders on record
91%
Avg confidence
BUY
Signal direction
Recent insider trades
| Date | Insider | Action | Type | Value | Confidence |
|---|---|---|---|---|---|
| Mar 31, 2026 | John Hamill | BUY | Open-market purchase | 25K | 1.00 |
| Mar 31, 2026 | Richard Peters | BUY | Open-market purchase | 100K | 1.00 |
| Jan 30, 2026 | Oren Gilad | BUY | Open-market purchase | 25K | 0.98 |
| Jan 30, 2026 | John Hamill | BUY | Open-market purchase | 5.1K | 0.96 |
| Dec 10, 2025 | John Hamill | BUY | Open-market purchase | 5.8K | 0.96 |
| Dec 10, 2025 | Marc Duey | BUY | Open-market purchase | 25K | 0.93 |
| Dec 10, 2025 | Oren Gilad | BUY | Open-market purchase | 25K | 1.00 |
| Apr 3, 2025 | Oren Gilad | BUY | Open-market purchase | 5.6K | 0.93 |
Aprea Therapeutics, Inc. has 28 total insider trades on record. Sign up to see the full history, track records, and evidence trails.
Want alerts when insiders trade APRE?
Sign up free to get notified, see the full trade history, and track insider conviction over time.
Sign up freeInsiderTrack aggregates publicly available SEC Form 4 filings. Data is provided for informational purposes only and should not be construed as investment advice. Always do your own research before making investment decisions.